CUPERTINO, CA / ACCESSWIRE / April 30, 2015 / Aemetis, Inc. (NASDAQ: AMTX) will host a conference call to review the Company's first quarter 2015 earnings report:

Date: Thursday, May 7, 2015

Time: 1:30 pm Pacific Time (PT)

Live Participant Dial In (Toll Free): +1 (877) 407-8133

Live Participant Dial In (International): +1 (201) 689-8040

Webcast URL: http://www.investorcalendar.com/event/173934

Attendees may submit questions during the Q&A portion of the conference call.

After May 7th, the webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Calls. The voice recording will also be available through May 14th, 2015 by dialing +1 (877) 660-6853 (Toll Free) or +1 (201) 612-7415 (International) and entering conference ID number 13607462.

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.

Investor Relations:

Michael Bayes
(415) 389-4670
michaelbayes@liviakis.com

Company Contact:

Satya Chillara
(408) 213-0939
schillara@aemetis.com

Media Contact:

Melanie Borchardt
(408) 213-0938
mborchardt@aemetis.com

SOURCE: Aemetis, Inc.